These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35416115)

  • 1. Comparison of mouse and human cytochrome P450 mediated-drug metabolising activities in hepatic and extrahepatic microsomes.
    Uehara S; Murayama N; Higuchi Y; Yoneda N; Yamazaki H; Suemizu H
    Xenobiotica; 2022 Mar; 52(3):229-239. PubMed ID: 35416115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450-dependent drug oxidation activities and their expression levels in liver microsomes of chimeric TK-NOG mice with humanized livers.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Pharmacokinet; 2022 Jun; 44():100454. PubMed ID: 35378494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkeys.
    Nakanishi Y; Matsushita A; Matsuno K; Iwasaki K; Utoh M; Nakamura C; Uno Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):288-94. PubMed ID: 21273732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Shimada T; Mimura M; Inoue K; Nakamura S; Oda H; Ohmori S; Yamazaki H
    Arch Toxicol; 1997; 71(6):401-8. PubMed ID: 9195021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison.
    Löfgren S; Hagbjörk AL; Ekman S; Fransson-Steen R; Terelius Y
    Xenobiotica; 2004 Sep; 34(9):811-34. PubMed ID: 15742976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.
    Uehara S; Murayama N; Nakanishi Y; Zeldin DC; Yamazaki H; Uno Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):654-61. PubMed ID: 21849623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.
    Yasumori T; Li QH; Yamazoe Y; Ueda M; Tsuzuki T; Kato R
    Pharmacogenetics; 1994 Dec; 4(6):323-31. PubMed ID: 7704038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.
    Nakamura A; Tougou K; Kitazumi H; Yamada T; Honjou K; Zinno A; Nonaka K; Mukai H
    Arzneimittelforschung; 2005; 55(12):744-8. PubMed ID: 16430028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
    Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
    Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    Shimada T; Tsumura F; Yamazaki H
    Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
    Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
    Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of irsogladine on P450-isoform specific activities in human hepatic microsomes.
    Nakamura A; Tougou K; Kitazumi H; Yamada T; Honjou K; Nonaka K; Mukai H
    Arzneimittelforschung; 2006; 56(7):547-52. PubMed ID: 16927538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytochrome P450-mediated drug metabolism in cats.
    Shah SS; Sanda S; Regmi NL; Sasaki K; Shimoda M
    J Vet Pharmacol Ther; 2007 Oct; 30(5):422-8. PubMed ID: 17803734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.